StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Endo International (ENDP) Weakness on Compounded Vasopressin Launch Bears Watching FDA Action - RBC
August 13, 2018 11:39 AM
The downside in Endo International (NASDAQ: ENDP) (-2.7%) is related to news Athenex (NASDAQ: ATNX) announced that it had launched ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
FDA
Next Articles
Endo International (ENDP) Reports Lift of Temporary Stay of FDA Litigation Following Launch of Bulk-Compounded Vasopressin Product by Section 503B Outsourcing Facility
August 15, 2018 6:05 AM
Endo International plc (ENDP) PT Raised to $17 at Mizuho Securities
August 14, 2018 5:46 AM
Endo International (ENDP): Vasopressin Headlines Likely Worse than Reality - Citi
August 13, 2018 1:30 PM
Endo International plc (ENDP) PT Raised to $16 at BMO Capital
August 13, 2018 8:26 AM
RBC Capital Upgrades Endo International plc (ENDP) to Outperform on Cycle Up-Turn
August 13, 2018 4:51 AM
PGA Golfer Tim Herron Teams Up with Endo Pharmaceuticals to Encourage Parents to Get Their Own Check-Ups This Back-to-School Season
August 9, 2018 7:30 AM
Endo International plc (ENDP) PT Raised to $19 at Citi
August 9, 2018 6:58 AM
Endo International plc (ENDP) PT Raised to $17 at Deutsche Bank
August 9, 2018 6:09 AM
